NSF's pharmaceutical remote auditing service can help to unlock supply chains and meet cGMP needs in clinical trial supply or routine commercial operations. Using their network of international GMP experts, e-rooms and videoconferencing, NSF’s four-step process can help to provide interim or conditional approval of facilities during periods of uncertainty or governmental restrictions.
This risk-based approach can be applied to:
- Manufacturers of raw materials, GMP components, drug substances and drug products
- Packaging, warehousing and distribution facilities
- Contractors and QC release/stability testing
- And more
Contact NSF at pharmamail@nsf.org or visit www.nsfpharma.org for more information.